EC Number   |
Inhibitors |
Structure |
|---|
   3.4.21.7 | pentasodium 2-[4-[2,5-bis(sulfonatooxy)phenyl]butanoyl]-6,7-bis(sulfonatooxy)-1,2,3,4-tetrahydroisoquinoline-3-carboxylate |
about 80% residual activity at 0.4 mM |
   |
| 3.4.21.7 | pentasodium 2-[[2,5-bis(sulfonatooxy)phenyl]acetyl]-6,7-bis(sulfonatooxy)-1,2,3,4-tetrahydroisoquinoline-3-carboxylate |
about 75% residual activity at 0.4 mM |
|
| 3.4.21.7 | pentasopentasodium 2-[[2,5-bis(sulfonatooxy)phenyl]acetyl]-6,7-bis(sulfonatooxy)-1,2,3,4-tetrahydroisoquinoline-3-carboxylatedium 2-[[2,5-bis(sulfonatooxy)phenyl]acetyl]-6,7-bis(sulfonatooxy)-1,2,3,4-tetrahydroisoquinoline-3-carboxylate |
about 70% residual activity at 0.4 mM |
|
| 3.4.21.7 | peptide GHRPYam |
delays appearance of plasmin activity |
|
| 3.4.21.7 | peroxynitrite |
50% inhibition at 280 microM and an enzyme concentration of 10 microM |
|
| 3.4.21.7 | Phe-Lys-benzylamide |
inhibition of fibrinolytic activity, no inhibition of amidolytic activity |
|
| 3.4.21.7 | PKSI-527 |
- |
|
| 3.4.21.7 | plasminogen activator inhibitor 1 |
- |
|
| 3.4.21.7 | plasminogen activator inhibitor I |
inhibits plasminogen activation to plasmin by urokinase-type plasminogen activator |
|
| 3.4.21.7 | plasminogen activator inhibitor II |
inhibits plasminogen activation to plasmin by urokinase-type plasminogen activator |
|
